ANSY JOHN: Open Payments
NPI 1265660047 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$754 in 54 payments from 7 companies in 2025. Trend: 2023 $127 · 2024 $885 · 2025 $754
Food & beverage: $754
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 16 | $269 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $219 |
| E.R. Squibb & Sons, L.L.C. | 14 | $163 |
| Alkermes, Inc. | 2 | $45 |
| OWP Pharmaceuticals, Inc. | 1 | $22 |
| Almatica Pharma LLC | 1 | $21 |
| Lundbeck LLC | 1 | $15 |
Products named: CAPLYTA, REXULTI, COBENFY, ABILIFY ASIMTUFII, ARISTADA, Subvenite, LOREEV XR.
Industry payments across NV — which companies pay providers there.
